Others, such as Wegovy and Zepbound, are approved specifically for chronic weight management
Thus, GLP-1R may be a potential link between DM and AD, and we look forward to discovering more about the mechanism of the link between these two diseases, as well as new applications of GLP-1R agonists in the treatment of AD
While genes don't determine your outcome alone, they provide insight into your baseline appetite biology and how you'll likely respond to stopping therapy
Good candidates generally have stable health status, understand the experimental nature of the therapy, and commit to appropriate monitoring protocols
"Activation of the central melanocortin system chronically reduces body mass without the necessity of long-term caloric restriction." American Journal of Physiology-Endocrinology and Metabolism
Yi, J., Zhu, J., Wu, J., Thompson, C